Genedrive Share Discussion Threads

[billthebank] 22/3/2021 09:18

FDA approval number allocated!!!

[iantrader2] 22/3/2021 09:00

Rayj1. Never take your predictions seriously and certainly don't boast about them

[billthebank] 22/3/2021 08:54

Looks like we are heading back to 150

[losses] 22/3/2021 08:47

Get ready for the 150 reminder for the 4th time

[rayj1] 21/3/2021 18:17

Truth hurts man I am just being straight

[blackvulture] 21/3/2021 10:58

Just filter the moron.

[losses] 19/3/2021 22:35

I will be first to remind you when we surpass 150

[mrshaungcm] 19/3/2021 22:11

OUR APPROACH
Mergers and acquisitions have been the driving force behind Danaher’s sustained growth for decades--the company has acquired hundreds of businesses since 1984. In the past several years, we've made notable additions to the Danaher portfolio, including Cepheid, Integrated DNA Technologies, AVT, and Pall. More than 50% of Danaher's total revenue today has been acquired in the past seven years.

But it’s not just about quantity—it217;s about quality and strategic value. We look for innovative science and technology companies whose businesses will benefit from the Danaher Business System (DBS).

Attractive Markets: We assess the market, including secular growth drivers and opportunities for consolidation.
Company Profile: We analyze the company’s market position and potential, including brand strength and margin expansion opportunities.
Value Creation: We consider potential in the context of DBS, our segments and our overall portfolio, including opportunities to extend global reach, advance technology and improve quality of life.
“We will continue to invest, as we have over a long period of time, in high-impact growth opportunities. We will continue to strengthen our market-leading positions and our overall portfolio, with a clear eye towards ensuring long-term, sustainable positions in attractive markets around the world.” Rainer Blair, President and Chief Executive Officer

We structure each acquisition carefully to meet the unique needs of both parties. Our decentralized operating structure preserves the strengths and independence of each business, while our global scope offers access to a wealth of resources, support and shared learnings. This balance positions our businesses to contribute to our shared purpose in unique and meaningful ways.

From adding exciting new technologies to contributing new perspectives and skills to our extended team, our focused acquisition strategy is essential to Helping Realize Life’s Potential for our customers, our companies and our shareholders.

[mrshaungcm] 19/3/2021 22:10

This is how danahar grows

[rayj1] 19/3/2021 21:47

Read my earlier post this week i clearly said 120! Well was not far out ! I predicted this all the way down from 150+. Again I see see this down next week and I will be very very surprised if we see 150 again.

[maxplus2] 19/3/2021 21:18

Please read today's tns by Danaher. This is what they are recommending to US Govt.

[sparrow9] 19/3/2021 21:13

How many predictions have you made to date ray1, your prediction for GDR end of next week is this based on the brokers wanting the shares ?

[rayj1] 19/3/2021 18:39

Notn60'but I see this edging on 100 by the end of next week. Massive losses. This stock is going to fail really really fail. So far all my predictions have been correct.

[amaretto1] 19/3/2021 17:09

These coming results need to be at least 5 million sales ...If not 60 pence ... mark my words.

[amaretto1] 19/3/2021 17:07

No .... absolutely had enough of FALSE promises .....Europe .. India .... no sales !!Disgrace. I've a sneaky feeling this bead system is the Betamax of video recorders.It's not being taken up !!

[maxplus2] 19/3/2021 15:41

We support the U.S. government's goal to expand screening because this is the right way to open up our schools, our economy and get people back to work in tandem with the massive vaccination drive that is underway," said Julie Sawyer Montgomery, president of Beckman Coulter Diagnostics. "The key to saving lives while vaccines are being put into arms is still masking, social distancing, regular testing, tracing and isolation. Our antigen assay makes the regular testing part of this equation a reality by enabling institutions and communities to implement low-cost, frequent, mass COVID-19 testing with automation, ease of handling and speed to enable scalability."

[maxplus2] 19/3/2021 15:40

See Danaher RNS (see my last msg) mentioning a commitment to support US Govt. In relation to Covid testing

[rayj1] 19/3/2021 15:29

What did I predict ... 120 .... bang on

[loafofbread] 19/3/2021 14:57

Should get the £15M euro deal next week.